Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remiazolam Combined With Esketamine for Pediatric Endoscopy Sedation
NCT05686863Completed
- Sponsor
- Tongji Hospital
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms), sponsored by Tongji Hospital. Primary endpoint: Sedation success rate. Started Jan 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05686863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05686863.